Q32 Bio Inc.
QTTB
$6.30
-$0.52-7.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 53.74M | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.74M | -- | -- | -- | -- |
| Cost of Revenue | 7.42M | 14.65M | 25.44M | 25.54M | 25.43M |
| Gross Profit | 46.32M | -14.65M | -25.44M | -25.54M | -25.43M |
| SG&A Expenses | 17.68M | 17.12M | 17.56M | 18.06M | 17.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.91M | 42.58M | 53.82M | 62.56M | 66.10M |
| Operating Income | 17.83M | -42.58M | -53.82M | -62.56M | -66.10M |
| Income Before Tax | 29.82M | -42.08M | -52.28M | -59.77M | -47.71M |
| Income Tax Expenses | -- | 21.00K | 21.00K | 21.00K | 21.00K |
| Earnings from Continuing Operations | 29.82 | -42.10 | -52.30 | -59.79 | -47.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.82M | -42.10M | -52.30M | -59.79M | -47.73M |
| EBIT | 17.83M | -42.58M | -53.82M | -62.56M | -66.10M |
| EBITDA | 18.22M | -42.16M | -53.36M | -62.08M | -65.62M |
| EPS Basic | 2.31 | -3.45 | -4.30 | -4.95 | -3.01 |
| Normalized Basic EPS | 0.92 | -2.88 | -3.42 | -3.82 | -2.66 |
| EPS Diluted | 2.30 | -3.45 | -4.31 | -4.95 | -10.37 |
| Normalized Diluted EPS | 0.91 | -2.88 | -3.42 | -3.82 | -3.03 |
| Average Basic Shares Outstanding | 49.20M | 48.82M | 48.65M | 48.42M | 37.22M |
| Average Diluted Shares Outstanding | 49.23M | 48.82M | 48.65M | 48.42M | 38.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |